Acetergamine
{{Chembox
| ImageFile = Acetergamine.svg
| ImageAlt =
| SystematicName = N-{[(8β)-6-Methylergolin-8-yl]methyl}acetamide
| OtherNames = 8β-acetylaminomethyl-6-methylergoline
(+)-N-Acetyl-9,10-dihydrolysergamine
|Section1=! colspan=2 style="background: #f8eaba; text-align: center;" |Identifiers
|-
|
|
|-
|
|
|-
|
|-
| ECHA InfoCard | 100.019.281 |-
|
|
|-
|
|
|-
| colspan="2" |
- InChI=1S/C18H23N3O/c1-11(22)19-8-12-6-15-14-4-3-5-16-18(14)13(9-20-16)7-17(15)21(2)10-12/h3-5,9,12,15,17,20H,6-8,10H2,1-2H3,(H,19,22)/t12-,15+,17+/m0/s1Key: SGZVEWGAZGOWGP-XGWLTEMNSA-N
|-
| colspan="2" |
- O=C(NC[C@@H]2C[C@@H]3c4cccc1c4c(cn1)C[C@H]3N(C2)C)C
|- |Section2=! colspan=2 style="background: #f8eaba; text-align: center;" |Properties
|-
|
| C18H23N3O
|- | Molar mass
| 297.402 g·mol−1
|- |Section3= }}
Acetergamine is a organic chemical compound; specifically it is a derivative of ergoline, making it a member of the ergotamine family of compounds. Acetergamine currently has no mainstream uses, however its potential as an alpha-1 blocker and vasodilator has led to it being covered in several patents concerning therapies for erectile dysfunction. It has also been investigated as a treatment for cerebellar ataxia.[1]
References
- ^ Ogawa, M (2004). "Pharmacological treatments of cerebellar ataxia". Cerebellum. 3 (2). London): 107–11. doi:10.1080/147342204100032331. PMID 15233578.